From October 1, 2022 to December 31, 2022, the company has repurchased 1,481,386 shares, representing 0.38% for $186.02 million. With this, the company has completed the repurchase of 1,481,386 shares, representing 0.38% for $186.02 million under the buyback announced on August 3, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
121.1 USD | -0.87% | +9.75% | +21.74% |
05-07 | UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating | MT |
05-06 | News Highlights : Top Financial Services News of the Day - Monday at 4 PM ET | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+49.67% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B | |
+21.07% | 11.81B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Tranche Update on Moderna, Inc.'s Equity Buyback Plan announced on August 3, 2022.